The breakout of the Coronavirus pandemic immediately set in motion the race to develop anti-viral medication and a vaccine for the disease. In the field of viral treatment, one may find two core research approaches – the first aimed at discovering new compounds, and the second earmarked for testing the efficacy of existing medications.

The scope of legal protection covering the results to be obtained under both research approaches, demonstrates the sensitive balance that exists between patent laws and the due protection of medicines.

To read the full article titled “Intellectual Property and the Coronavirus”, written by partners, Tal Band and Ran Vogel, as published on the site Expert Guides, click here >>